Long-term effects on bone mineral density of pamidronate given at the time of renal transplantation
Authors:
- Stanley L.-S. FanSFStanley L.-S. Fan
- Serita KumarSKSerita Kumar
- John CunninghamJCJohn Cunningham
- 1 June 2003
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 63 (6) , 2275-2279
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Bisphosphonates in renal osteodystrophyCurrent Opinion in Nephrology and Hypertension, 2001
- Effect of Ibandronate on Bone Loss and Renal Function after Kidney TransplantationJournal of the American Society of Nephrology, 2001
- Pamidronate therapy as prevention of bone loss following renal transplantationKidney International, 2000
- Bone disease in patients with long-term renal transplantation and normal renal functionAmerican Journal of Kidney Diseases, 2000
- High Prevalence of Low Bone Turnover and Occurrence of Osteomalacia after Kidney TransplantationJournal of the American Society of Nephrology, 2000
- INCREASED FRACTURE RATE IN DIABETES MELLITUS AND FEMALES AFTER RENAL TRANSPLANTATION1Transplantation, 1999
- BONE FRACTURE AND OSTEODENSITOMETRY WITH DUAL ENERGY X-RAY ABSORPTIOMETRY IN KIDNEY TRANSPLANT RECIPIENTSTransplantation, 1994
- Loss of Regional Bone Mineral Density in the First 12 Months following Renal TransplantationNephron, 1994
- Rapid Loss of Vertebral Mineral Density after Renal TransplantationNew England Journal of Medicine, 1991
- Cyclosporin-Ain VivoProduces Severe Osteopenia in the Rat: Effect of Dose and Duration of Administration*Endocrinology, 1988